脑部放疗,上午比下午敏感许多!
! _5 c. _. `7 q: c. h3 M3 p& v
! R8 I" P3 t ~8 b* Z4 w8 |% ^4 S; m
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9." b- b0 B, `, j
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?1 C$ d8 R' ]* O; k0 T
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
& E0 q* Y& ~. U" _2 ?$ I# X6 `; DSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.8 j! F3 l9 `/ _2 K6 d4 E# M* r& D' O
. i% V0 ]; O. a
Abstract
: m* ~1 N) i: D0 p. lBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
" V j" c% w! `5 L- h
* I5 w3 X# P7 k; iMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
- ~% I2 [/ Q( ]" \6 D5 h) d! y3 k( T i3 U$ \6 z# D' }; M' k2 ^
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).8 _ X* r" [8 f' m
* v1 q2 ]" L( B3 `) e5 pCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
# @; d3 |8 E- j! K2 E" g" F; S! R2 f2 m& E# _8 A0 @- `7 I& ]
|